Page last updated: 2024-09-03

a 68930 and Spinal Cord Injuries

a 68930 has been researched along with Spinal Cord Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, F; Hou, J; Huang, Y; Jiang, W; Li, M; Liu, J; Ren, W; Sun, T; Zhu, L1
Bian, Z; He, F; He, Q; Jiang, W; Li, M; Liu, J; Sun, T; Wang, X; Zhu, L1

Trials

2 trial(s) available for a 68930 and Spinal Cord Injuries

ArticleYear
Dopamine D1 Receptor Agonist A-68930 Inhibits NLRP3 Inflammasome Activation, Controls Inflammation, and Alleviates Histopathology in a Rat Model of Spinal Cord Injury.
    Spine, 2016, Volume: 41, Issue:6

    Topics: Animals; Chromans; Cytokines; Female; Histocytochemistry; Inflammasomes; Inflammation; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Spinal Cord; Spinal Cord Injuries

2016
Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation and protects rats from spinal cord injury-induced acute lung injury.
    Spinal cord, 2016, Volume: 54, Issue:11

    Topics: Acute Lung Injury; Animals; Capillary Permeability; Chromans; Cytokines; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; NLR Family, Pyrin Domain-Containing 3 Protein; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Time Factors

2016